England Unveils £680m Innovative Medicines Fund
Bigger Than Had Been Proposed, Fund Extends Cancer Drugs Fund To Other Treatment Areas
England’s Innovative Medicines Fund is aimed at providing earlier access to promising new treatments, including gene therapies, when further data is needed for routine commissioning.
You may also be interested in...
While they await further details on England’s new Innovative Medicines Fund, industry and other stakeholders are asking questions about how far the fund – due for launch later this year – will be adapted to fit non-cancer therapies.
England’s health technology assessment body NICE did not recover costs for technology appraisals through fees thanks to the COVID-19 pandemic.
Reimbursement timelines in Italy and France for the treatments in question have been quicker than the average.